Steven M Kurtz1, Edmund C Lau2, Kevin L Ong3, Edward M Adler4, Frank R Kolisek5, Michael T Manley6. 1. Exponent Inc, Philadelphia, Pennsylvania; School of Biomedical Engineering, Science, and Health Systems, Drexel University, Philadelphia, Pennsylvania. 2. Exponent Inc, Menlo Park, California. 3. Exponent Inc, Philadelphia, Pennsylvania. 4. Hospital for Joint Diseases, New York, New York. 5. OrthoIndy, Indianapolis, Indiana. 6. Stryker Orthopaedics, Mahwah, New Jersey.
Abstract
BACKGROUND: The purpose of this study was to analyze the hospital, clinical, and patient factors associated with inpatient readmission after total hip arthroplasty (THA) in the Medicare population and to understand the primary reasons for readmission. METHODS: The Medicare 100% national hospital claims database was used to identify 442,333 older patients (65+) with a primary THA in 3730 hospitals between 2010 and 2013. A multilevel logistic regression analysis with a clustered data structure was used to investigate the risk of all-cause 30- and 90-day readmission, incorporating hospital, clinical, and patient factors. RESULTS: At 30 days, 5.8% (median) of the patients were readmitted, whereas at 90 days, 10.5% (median) were readmitted. Geographic census region, hospital procedure volume, and nonprofit ownership were the only significant hospital factors among those we studied. Overall, clinical factors explained more of the variation in readmission rates than general hospital factors. Use of a perioperative transfusion was associated with 14% greater risk, patients discharged to home had 28% lower risk, and surgeon volume and length of stay were also significant risk factors. The top 5 most frequently reported primary reasons for 30-day readmission in THA were procedure related: dislocation (5.9%), deep infection (5.1%), wound infection (4.8%), periprosthetic fracture (4.4%), or hematoma (3.4%). CONCLUSION: These findings support further optimization of the delivery of care-both intraoperative and postoperative-to reduce the broad variation in hospital readmissions.
BACKGROUND: The purpose of this study was to analyze the hospital, clinical, and patient factors associated with inpatient readmission after total hip arthroplasty (THA) in the Medicare population and to understand the primary reasons for readmission. METHODS: The Medicare 100% national hospital claims database was used to identify 442,333 older patients (65+) with a primary THA in 3730 hospitals between 2010 and 2013. A multilevel logistic regression analysis with a clustered data structure was used to investigate the risk of all-cause 30- and 90-day readmission, incorporating hospital, clinical, and patient factors. RESULTS: At 30 days, 5.8% (median) of the patients were readmitted, whereas at 90 days, 10.5% (median) were readmitted. Geographic census region, hospital procedure volume, and nonprofit ownership were the only significant hospital factors among those we studied. Overall, clinical factors explained more of the variation in readmission rates than general hospital factors. Use of a perioperative transfusion was associated with 14% greater risk, patients discharged to home had 28% lower risk, and surgeon volume and length of stay were also significant risk factors. The top 5 most frequently reported primary reasons for 30-day readmission in THA were procedure related: dislocation (5.9%), deep infection (5.1%), wound infection (4.8%), periprosthetic fracture (4.4%), or hematoma (3.4%). CONCLUSION: These findings support further optimization of the delivery of care-both intraoperative and postoperative-to reduce the broad variation in hospital readmissions.
Authors: Pablo A Slullitel; Martín Estefan; Wilber M Ramírez-Serrudo; Fernando M Comba; Gerardo Zanotti; Francisco Piccaluga; Martín A Buttaro Journal: Int Orthop Date: 2018-03-10 Impact factor: 3.075
Authors: Steven M Kurtz; Edmund C Lau; Kevin L Ong; Edward M Adler; Frank R Kolisek; Michael T Manley Journal: Clin Orthop Relat Res Date: 2017-12 Impact factor: 4.176
Authors: Cheryl K Zogg; Jason R Falvey; Justin B Dimick; Adil H Haider; Kimberly A Davis; Johnathan N Grauer Journal: J Arthroplasty Date: 2019-02-18 Impact factor: 4.757
Authors: Edward C Rainville; Carl Asche; Jinma Ren; MinChul Kim; Lucas Walker; B Ted Maurer; Daniel R Knolhoff; Kyle M Shick Journal: Hosp Pharm Date: 2019-04-25
Authors: Addie Middleton; Yong-Fang Kuo; James E Graham; Amol Karmarkar; Yu-Li Lin; James S Goodwin; Allen Haas; Kenneth J Ottenbacher Journal: J Am Med Dir Assoc Date: 2018-10 Impact factor: 4.669
Authors: Matthew S Lee; Brent K Hollenbeck; Mary K Oerline; Ted A Skolarus; Bruce L Jacobs; Rita Jen; Amy N Luckenbaugh; Vahakn Shahinian; Tudor Borza Journal: Urol Pract Date: 2018-10-07